Get started

Toptrader

MLND Technical Analysis.Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. Its lead asset, livoletide, is an unacylated ghrelin analogue being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disease characterized by hyperphagia, a chronic unrelenting hunger, that leads to obesity, metabolic dysfunction, reduced quality of life and early mortality. The company is also developing nevanimibe, an ACAT1 inhibitor for the treatment of two orphan adrenal diseases: classic congenital adrenal hyperplasia (CAH) and endogenous Cushing's syndrome (CS). If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
MLong
by yura_trades
2
LQDA Technical Analysis.Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:LQDALong
by yura_trades
GBS Technical Analysis.Glucose Biosensor Systems (Greater China) Holdings Inc is a United States based company engaged in manufacturing of Saliva Glucose Biosensor (SGB). SGB uses saliva to measure glucose non-invasively. The Saliva Glucose Test consists of the SGB which is a single use disposable saliva biosensor and the software app that interfaces the SGB with its digital information system. If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
GLong
by yura_trades
1
CALA Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications. If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
CLong
by yura_trades
ABIO a great long opportunity!ARCA biopharma Inc is a biopharmaceutical company. It applies precision medicine approach to develop genetically targeted therapies for cardiovascular diseases. The firm's lead product candidate is Gencaro. The company adopts genotype-directed comparative effectiveness trial of Bucindolol and Toprol-XL for prevention of symptomatic atrial fibrillation in patients with heart failure. It establishes long-term relationships with partners such as Medtronic, Laboratory Corporation of America and the University of Colorado. If you understand the idea,🎯 press a thumb up! 👍👍👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
ALong
by yura_trades
Bitcoin Is Exhausted | Alt-Season Inbound [4HR] BITCOIN IS EXHAUSTED or is it? - As we move into 2021, we watch as news outs from Cramer to NELK boys push the conversation toward Bitcoin and other notorious coins as Bitcoin sets new ATHs . Everyone seems to be scrambling for a "price target" from such sources but no one seems to be able to put a finger on it. Bitcoin set a new all-time high at $34778.11, before showing faint signs of clear exhaustion. Bitcoin could very well be forming another wedge forming as we saw in Nov/Dec before it broke, but we MUST consider a key level on the technical side of things (which seems like one of the only sane indications). ( CRYPTOCAP:BTC CRYPTOCAP:TOTAL2 CRYPTOCAP:ETH ) (1) Bitcoins runs could've been anticipated, starting with the break of the clear break of resistance toward the end of July. This first break wouldn't indicate a direct buy as we'd look for that retest as support before confirming a change in trend (regardless of timeframe). (2) Bitcoin was confirmed bullish on the retest of the previous resistance, which confirmed it as support moving forward. Bitcoin was confirmed bullish at the start of October which left us with a few targets in mind... $24,970, $19,798, and beyond with the breakout of $20k. (3) Once Bitcoin made the break of $13,970 it engaged in a series of ladders before starting the parabolic jump the week of Dec 14th. (4) Bitcoin is exhausted... Or is it? Putting a finger on Bitcoin during a move like this is extremely difficult. With that said, I believe I've found a trendline that seems to be quite accurate as of now. As we tested and set an all-time high of $34778.11, we also come very very close to smacking right of (4) . Bitcoin is extremely volatile and has a few options at this level. Either we'll see Bitcoin push, break, and continue past $35k or we'll see a nice cool-off. I believe Bitcoin will perform a cool-off up until late Summer/early winter, which will lead to a small bounce as it will set another range to be traded at over the next years. Google Trends: (trends.google.com) Talk about Bitcoin didn't really start "trending" until October, we can confirm this on Google Trends. The change in the trend of Google searches is clearly reflected on the chart. This doesn't say much but it gives you a better image of how the news/hype travels. DCJ
by DotcomJack
1